Vibrio and Pseudomonas species have been shown to be part of the normal microbiota of Atlantic salmon (Salmo salar L.), with some strains causing disease in fish. The factors affecting their prevalence and persistence in the salmon gut, however, have not been well studied. In this study, we collected 340 Vibrio and 150 Pseudomonas isolates from the hindgut of farmed Tasmanian Atlantic salmon, fed with two commercially available diets. Samples were collected every 6-8 weeks between July 2011 and May 2012. Isolates from selective agar were initially identified using biochemical tests and confirmed using genus-specific primers and 16S ribosomal RNA (16S rRNA) sequencing. Random amplified polymorphic DNA (RAPD) PCR was used to type both Pseudomonas and Vibrio; the latter was further typed using a biochemical fingerprinting method (PhP-RV plates). We observed low species diversity with strains comprising Vibrio ichthyoenteri/Vibrio scophthalmi, Vibrio crassostreae/Vibrio splendidus, Aliivibrio finisterrensis, Photobacterium phosphoreum and Pseudomonas fragi. Out of 340 Vibrio isolates, 238 (70 %) belonged to 21 clonal types and were found predominantly during summer when water temperatures reached 15 to 21 °C. Of these, the four major clonal types were found in multiple samples (70 %). P. fragi, on the other hand, was only found during the colder water temperatures and belonged to 18 clonal types. The presence of both groups of bacteria and their clonal types were independent of the fish diets used, suggesting that the water temperature was the main factor of the prevalence and persistence of these bacteria in the gut of Atlantic salmon.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00248-014-0462-x | DOI Listing |
Infections with bacteria of the genus Pasteurella have increased in occurrence in Atlantic salmon (Salmo salar) farms in Norway since 2018. This increase coincides with increased use of non-medicinal treatments against the parasitic salmon louse, Lepeophtheirus salmonis, in the farms. Here, we analysed the statistical association between the use of non-medicinal delousing methods and pasteurellosis in salmon farming in western Norway, from 2018 to 2023.
View Article and Find Full Text PDFFoods
January 2025
Nofima AS, Richard Johnsensgate 4, 4068 Stavanger, Norway.
The aim of this study was to develop a chilled, texture-modified salmon product for dysphagia patients, enriched with dairy and fish hydrolysate proteins. The challenge was to create a product with appealing sensory qualities and texture that meets level 5 (minced & moist) of the IDDSI framework. Atlantic salmon () was heat-treated (95 °C/15 min), blended, and reconstructed by adding texture modifiers, casein and whey protein, and enzymatically derived fish hydrolysate.
View Article and Find Full Text PDFToxins (Basel)
January 2025
Scottish Association for Marine Science-UHI, Oban PA37 1QA, UK.
This study explored harmful algal bloom (HAB) risk as a function of exposure, hazard and vulnerability, using Scotland as a case study. Exposure was defined as the fish biomass estimated to be lost from a bloom event, based on the total recorded annual production. Hazard was estimated from literature-reported bloom events.
View Article and Find Full Text PDFComp Biochem Physiol A Mol Integr Physiol
January 2025
Department of Zoology, University of British Columbia, Vancouver, Canada.
In a previous study, we demonstrated successful regeneration of Atlantic salmon gill tissue following up to 50 % filament resection. The present study explored 1) the capacity of gill tissue to regenerate following more severe trauma, 2) if regeneration potential varies across regions of the arch, and 3) how tissue loss impacts the physiology of neighboring unresected filaments. Fish were divided between two resected groups and a control non-resected one.
View Article and Find Full Text PDFACS Environ Au
January 2025
Department of Wildlife, Fish, and Environmental Studies, Swedish University of Agricultural Sciences, Umeå SE-907 36, Sweden.
Pharmaceutical contaminants have spread in natural environments across the globe, endangering biodiversity, ecosystem functioning, and public health. Research on the environmental impacts of pharmaceuticals is growing rapidly, although a majority of studies are still conducted under controlled laboratory conditions. As such, there is an urgent need to understand the impacts of pharmaceutical exposures on wildlife in complex, real-world scenarios.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!